PodParley PodParley
PodParley
JAAD Podcast: High-dose, high frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa episode artwork

EPISODE · Jul 23, 2020

JAAD Podcast: High-dose, high frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

from AAD's Dialogues in Dermatology

Steven R. Cohen, MD, PhD, FAAD interviewed by Vinod Namburdiri, MD, MBA, FAAD

Episode metadata supplied by the publisher feed · Published Jul 23, 2020

Embed this episode

NOW PLAYING

JAAD Podcast: High-dose, high frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this AAD's Dialogues in Dermatology episode published?

This episode was published on July 23, 2020.

Can I download this AAD's Dialogues in Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!